A MODEL FOR TUMOR SUPPRESSION USING H-1 PARVOVIRUS

被引:81
作者
TELERMAN, A
TUYNDER, M
DUPRESSOIR, T
ROBAYE, B
SIGAUX, F
SHAULIAN, E
OREN, M
ROMMELAERE, J
AMSON, R
机构
[1] FREE UNIV BRUSSELS, FAC SCI, DEPT MOLEC BIOL, B-1640 BRUSSELS, BELGIUM
[2] GERMAN CANC RES CTR, DEPT TUMOR VIROL, W-6900 HEIDELBERG 1, GERMANY
[3] INST PASTEUR, MOLEC ONCOL LAB, CNRS, URA 1160, F-59019 LILLE, FRANCE
[4] HOP ST LOUIS, CENT HEMATOL LAB, F-75475 PARIS, FRANCE
[5] HOP ST LOUIS, HEMATOL MOLEC LAB, F-75475 PARIS, FRANCE
[6] WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL
关键词
CANCER GENETICS; TUMOR SUPPRESSOR GENES; P53; ONCOGENES;
D O I
10.1073/pnas.90.18.8702
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A model system is proposed to investigate, at the molecular level, the pathways of tumor suppression. As a tool for the selection of cells with a suppressed phenotype, we used the H-1 parvovirus that preferentially kills various neoplastic cells. From the human K562 leukemia cells, we isolated a clone, KS, that is resistant to the cytopathic effect of the H-1 virus and displays a suppressed malignant phenotype. The suppressed malignancy and the cellular resistance to H-1 killing appear to depend on the activity of wild-type p53. Whereas the KS cells express wild-type p53, the protein is undetectable in the parental K562 cells. Experiments with p53 mutants suggest that wild-type p53, in its functionally intact state, contributes to the resistance against the cytopathic effect of H-1 parvovirus.
引用
收藏
页码:8702 / 8706
页数:5
相关论文
共 41 条
  • [1] THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS
    AMSON, R
    SIGAUX, F
    PRZEDBORSKI, S
    FLANDRIN, G
    GIVOL, D
    TELERMAN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8857 - 8861
  • [2] AMSON RB, 1989, ONCOGENE, V4, P243
  • [3] WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION
    BARGONETTI, J
    FRIEDMAN, PN
    KERN, SE
    VOGELSTEIN, B
    PRIVES, C
    [J]. CELL, 1991, 65 (06) : 1083 - 1091
  • [4] PARVOVIRUS REPLICATION
    BERNS, KI
    [J]. MICROBIOLOGICAL REVIEWS, 1990, 54 (03) : 316 - 329
  • [5] PROGRAMMED KILLING OF HUMAN-CELLS BY MEANS OF AN INDUCIBLE CLONE OF PARVOVIRAL GENES ENCODING NONSTRUCTURAL PROTEINS
    CAILLETFAUQUET, P
    PERROS, M
    BRANDENBURGER, A
    SPEGELAERE, P
    ROMMELAERE, J
    [J]. EMBO JOURNAL, 1990, 9 (09) : 2989 - 2995
  • [6] CHEN YQ, 1986, CANCER RES, V46, P3574
  • [7] THE AUTONOMOUSLY REPLICATING PARVOVIRUSES OF VERTEBRATES
    COTMORE, SF
    TATTERSALL, P
    [J]. ADVANCES IN VIRUS RESEARCH, 1987, 33 : 91 - 174
  • [8] DELBINO G, 1990, CANCER RES, V50, P5746
  • [9] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221
  • [10] THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION
    FINLAY, CA
    HINDS, PW
    LEVINE, AJ
    [J]. CELL, 1989, 57 (07) : 1083 - 1093